Michelson Diagnostics Limited

Michelson Diagnostics Limited specializes in optical coherence tomography (OCT) devices, specifically the VivoSight Dx Pro and VivoSight Dx Standoff. These systems are engineered for high-resolution imaging of retinal and anterior segment structures, helping clinicians diagnose and monitor ophthalmic conditions like macular degeneration and glaucoma. The devices provide detailed cross-sectional images of the eye, supporting precise diagnostic evaluations.

The company is headquartered in the United Kingdom. This location reflects its focus on developing and distributing medical imaging technology within the European market and adhering to relevant regulatory standards.

Michelson Diagnostics Limited’s devices are registered in the eudamed database, which is the official EU registry for medical devices under the Medical Device Regulation (MDR). This registration ensures transparency and compliance with EU requirements for Class IIa devices.

The company’s devices, including the VivoSight Dx Pro and VivoSight Dx Standoff, are classified as Class IIa under the EU Medical Device Regulation (MDR). This classification is based on their intended use for diagnostic imaging of the eye, where they pose moderate risks that require additional scrutiny and conformity assessment procedures.